Skip to main content

Meet us

Annual World ADC San Diego 2025

3. - 6. November

BIO-Europe

3. - 5. November

Deutsches Eigenkapitalforum

24. - 26. November

ASH Annual Meeting

6. - 9. Dezember

    Current Presentations

    Webcast "Strategic Focusing" as of 25 September 2025

    IMS - International Myeloma Society Annual Meeting

    R&D Webinar June 2025 - Replay: Pioneering New Treatment Options in Relapsed or Refractory Multiple Myeloma with a New Amanitin-based ADC

    Company presentation September 2025

    Upcoming Conferences 2025

    EventDateLocation
    BioJapan
    8. - 10. Oktober
    Yokohama
    Annual World ADC San Diego 2025
    3. - 6. November
    San Diego
    BIO-Europe
    3. - 5. November
    Wien
    Deutsches Eigenkapitalforum
    24. - 26. November
    Frankfurt
    ASH Annual Meeting
    6. - 9. Dezember
    Orlando

    Past Conferences 2024/2025

    EventDateLocationLinkDownload
    IMS - International Myeloma Society Annual Meeting
    17. - 20. September
    Toronto
    ADC & Novel Conjugates Partnering & Investment Summit
    9. - 10. September
    Boston
    The Antibody Series 2025
    9. - 12. September
    Porto
    ADC Linker & Conjugation Summit
    19. - 21. August
    Boston
    ADC Toxicity Summit
    8. - 10. Juli
    Boston
    Webinar: Pioneering New Treatment Options in Relapsed or Refractory Multiple Myeloma with a New Amanitin-based ADC
    17. Juni, 5 pm CEST
    Bio International Convention
    16. - 19. Juni
    Boston
    Zacks SCR Life Sciences Investor Forum
    12. Juni
    EHA Annual Congress
    12. - 15. Juni
    Mailand
    World ADC Asia Congress
    10. - 12. Juni
    Seoul
    2025 ASCO Annual Meeting
    30. Mai - 3. Juni
    Chicago
    Bio €quity Europe 2025
    12. - 14. Mai
    Brügge
    Frühjahrskonferenz 2025 - Equity Forum
    12. - 14. Mai
    Frankfurt
    ADC Payload Summit
    6. - 8. Mai
    Boston
    Swiss Biotech Day 2025
    5. - 6. Mai
    Basel

    Presentations are archived information about Heidelberg Pharma AG and were current at the time they were published. Archived information may have been replaced by more recent information published by the company in more recent presentations, press releases or elsewhere. The presentations and recordings may contain forward-looking statements based on management's beliefs as of the date of publication. Actual developments may differ materially from the information contained in the publications due to various factors.